| Dr Seniora Mathews, MD | |
|
468 N Camden Dr, Ste 353, Beverly Hills, CA 90210-4507 | |
| (310) 601-3074 | |
| Not Available |
| Full Name | Dr Seniora Mathews |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 468 N Camden Dr, Beverly Hills, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104977875 | NPI | - | NPPES |
| 00A939220 | Other | CA | MEDI-CAL |
| 141604001 | Medicaid | AR | |
| EV392Z | Other | CA | MEDICARE PTAN |
| Entity Name | County Of Stanislaus |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154524445 PECOS PAC ID: 0648183996 Enrollment ID: O20031111000935 |
News Archive
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.
On Monday a 44 year old man from Marian west of Mackay, called an ambulance after he developed heart problems. The paramedics reached his home more than an hour later to find him dead. The man called an ambulance at 1.31pm (AEST) on Monday but the Queensland Ambulance Service (QAS) said paramedics did not arrive until 2.46pm.
Patients with acute deep vein thrombosis (DVT) develop potentially dangerous blood clots and can suffer severe leg pain and swelling. Doctors with Virginia Interventional & Vascular Associates (VIVA) report success over the past two years in treating acute DVT patients with a procedure called isolated pharmacomechanical thrombolysis (IPMT), which destroys clots much faster than traditional therapies.
As the obesity epidemic grows in the U.S., doctors are discovering more and more far reaching health concerns for overweight children.
In an article published recently in the journal Nature Communications, researchers affiliated with the University of São Paulo in Brazil describe the central role played by an enzyme called phosphatidylinositol 3-kinase gamma in regulating the immune response against Trypanosoma cruzi, the protozoan parasite that causes Chagas disease.
› Verified 9 days ago
| Entity Name | County Of Stanislaus |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831394998 PECOS PAC ID: 0648183996 Enrollment ID: O20031111000939 |
News Archive
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.
On Monday a 44 year old man from Marian west of Mackay, called an ambulance after he developed heart problems. The paramedics reached his home more than an hour later to find him dead. The man called an ambulance at 1.31pm (AEST) on Monday but the Queensland Ambulance Service (QAS) said paramedics did not arrive until 2.46pm.
Patients with acute deep vein thrombosis (DVT) develop potentially dangerous blood clots and can suffer severe leg pain and swelling. Doctors with Virginia Interventional & Vascular Associates (VIVA) report success over the past two years in treating acute DVT patients with a procedure called isolated pharmacomechanical thrombolysis (IPMT), which destroys clots much faster than traditional therapies.
As the obesity epidemic grows in the U.S., doctors are discovering more and more far reaching health concerns for overweight children.
In an article published recently in the journal Nature Communications, researchers affiliated with the University of São Paulo in Brazil describe the central role played by an enzyme called phosphatidylinositol 3-kinase gamma in regulating the immune response against Trypanosoma cruzi, the protozoan parasite that causes Chagas disease.
› Verified 9 days ago
| Entity Name | County Of Solano |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508072588 PECOS PAC ID: 7911893177 Enrollment ID: O20040224001362 |
News Archive
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.
On Monday a 44 year old man from Marian west of Mackay, called an ambulance after he developed heart problems. The paramedics reached his home more than an hour later to find him dead. The man called an ambulance at 1.31pm (AEST) on Monday but the Queensland Ambulance Service (QAS) said paramedics did not arrive until 2.46pm.
Patients with acute deep vein thrombosis (DVT) develop potentially dangerous blood clots and can suffer severe leg pain and swelling. Doctors with Virginia Interventional & Vascular Associates (VIVA) report success over the past two years in treating acute DVT patients with a procedure called isolated pharmacomechanical thrombolysis (IPMT), which destroys clots much faster than traditional therapies.
As the obesity epidemic grows in the U.S., doctors are discovering more and more far reaching health concerns for overweight children.
In an article published recently in the journal Nature Communications, researchers affiliated with the University of São Paulo in Brazil describe the central role played by an enzyme called phosphatidylinositol 3-kinase gamma in regulating the immune response against Trypanosoma cruzi, the protozoan parasite that causes Chagas disease.
› Verified 9 days ago
| Entity Name | County Of Stanislaus |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023681301 PECOS PAC ID: 0648183996 Enrollment ID: O20041108000570 |
News Archive
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.
On Monday a 44 year old man from Marian west of Mackay, called an ambulance after he developed heart problems. The paramedics reached his home more than an hour later to find him dead. The man called an ambulance at 1.31pm (AEST) on Monday but the Queensland Ambulance Service (QAS) said paramedics did not arrive until 2.46pm.
Patients with acute deep vein thrombosis (DVT) develop potentially dangerous blood clots and can suffer severe leg pain and swelling. Doctors with Virginia Interventional & Vascular Associates (VIVA) report success over the past two years in treating acute DVT patients with a procedure called isolated pharmacomechanical thrombolysis (IPMT), which destroys clots much faster than traditional therapies.
As the obesity epidemic grows in the U.S., doctors are discovering more and more far reaching health concerns for overweight children.
In an article published recently in the journal Nature Communications, researchers affiliated with the University of São Paulo in Brazil describe the central role played by an enzyme called phosphatidylinositol 3-kinase gamma in regulating the immune response against Trypanosoma cruzi, the protozoan parasite that causes Chagas disease.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Seniora Mathews, MD 3422 Business Center Dr., Ste 106 Box 46, Pearland, TX 77584-0118 Ph: (870) 530-1038 | Dr Seniora Mathews, MD 468 N Camden Dr, Ste 353, Beverly Hills, CA 90210-4507 Ph: (310) 601-3074 |
News Archive
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.
On Monday a 44 year old man from Marian west of Mackay, called an ambulance after he developed heart problems. The paramedics reached his home more than an hour later to find him dead. The man called an ambulance at 1.31pm (AEST) on Monday but the Queensland Ambulance Service (QAS) said paramedics did not arrive until 2.46pm.
Patients with acute deep vein thrombosis (DVT) develop potentially dangerous blood clots and can suffer severe leg pain and swelling. Doctors with Virginia Interventional & Vascular Associates (VIVA) report success over the past two years in treating acute DVT patients with a procedure called isolated pharmacomechanical thrombolysis (IPMT), which destroys clots much faster than traditional therapies.
As the obesity epidemic grows in the U.S., doctors are discovering more and more far reaching health concerns for overweight children.
In an article published recently in the journal Nature Communications, researchers affiliated with the University of São Paulo in Brazil describe the central role played by an enzyme called phosphatidylinositol 3-kinase gamma in regulating the immune response against Trypanosoma cruzi, the protozoan parasite that causes Chagas disease.
› Verified 9 days ago
Mandana Torabi, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 9401 Wilshire Blvd Ste 760, Beverly Hills, CA 90212 Phone: 424-343-6496 Fax: 877-386-4735 | |
Allie R Shapiro, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 9171 Wilshire Blvd Ste 600, Beverly Hills, CA 90210 Phone: 310-746-4395 Fax: 310-432-7065 | |
Guven Uzun, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 415 N Crescent Dr #220, Beverly Hills, CA 90210 Phone: 310-888-2877 Fax: 310-205-9258 | |
Dr. John Thornton Lundgren, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 9777 Wilshire Blvd., Suite 905, Beverly Hills, CA 90212 Phone: 310-273-7495 Fax: 310-273-0714 | |
Mr. A Kevin Aminian, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 8920 Wilshire Blvd, Suite 548, Beverly Hills, CA 90211 Phone: 310-358-0700 Fax: 310-358-0717 | |
Nancy Wolf, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1242 Angelo Dr, Beverly Hills, CA 90210 Phone: 310-858-8149 | |
Elise Deborah Resnick, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 9730 Wilshire Blvd, Suite 205a, Beverly Hills, CA 90212 Phone: 310-815-9178 |